Rhapsido is the first and only Bruton’s tyrosine kinase (BTK) inhibitor approved for chronic spontaneous urticaria (CSU). The FDA has approved Rhapsido (remibrutinib), an oral treatment for adult ...

The FDA approved oral remibrutinib (Rhapsido) as a second-line treatment for chronic spontaneous urticaria (CSU), or chronic hives, Novartis announced on Tuesday. Indicated for adults with stubborn ...

Weeping eczema can feel uncomfortable and distressing. By partnering with a board-certified dermatologist, you can manage it at home and get relief. When fluid leaks from eczema spots and patches on ...

The FDA approved remibrutinib, the first oral treatment for adults with persistent chronic spontaneous urticaria despite H1 antihistamine treatment, according to a press release. Remibrutinib ...

The twice-daily pill, Rhapsido, is approved for patients with symptoms of chronic spontaneous urticaria (CSU) despite standard therapies. CSU is a long-term skin condition without a known cause, ...

A medication used to treat asthma can now be used to help people with food allergies avoid severe reactions, the U.S. Food and Drug Administration said Friday. Xolair, the brand name for the drug ...

An anxiety rash looks like small, inflamed patches on the skin and can resemble allergic rashes. Treatment includes managing anxiety through therapy and medications and using soothing lotions or ...

Shiitake mushrooms are among the most popular types of mushrooms. They have a broad, brown cap with a thin, curved stem. Like other mushrooms, they’re rich in beneficial carbohydrates, vitamins, ...

(CNN) — Dr. Anna Wolfson says she sees dangerous misuse of the allergy medication diphenhydramine in her clinic every day. “If someone has an allergic reaction to a food, people will say, ‘Don’t worry ...